Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$222K Buy
+527
New +$210K 0.09% 119
2026
Q2
– Sell
-630
Closed -$222K – 128
2026
Q1
$222K Sell
630
-15
-2% -$5.35K 0.1% 111
2025
Q4
$211K Buy
+645
New +$205K 0.09% 115
2025
Q2
– Sell
-645
Closed -$201K – 115
2025
Q1
$201K Buy
+645
New +$190K 0.1% 102
2024
Q4
– Sell
-645
Closed -$208K – 111
2024
Q3
$208K Hold
645
– – 0.12% 112
2024
Q2
$202K Buy
+645
New +$189K 0.12% 103

Other funds holding AMGN

626 Financial's AMGN Position: Q3 2026 in Review

626 Financial opened a new position in Amgen (AMGN) in Q3 2026: 527 shares worth $222K. The stake represents 0.09% of the portfolio and ranks #119 among its holdings. This is a return to the name: 626 Financial previously reported a position in AMGN as recently as Q1 2026.

626 Financial first reported a position in AMGN in Q2 2024 and has held it in 6 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • 626 Financial held 527 shares of Amgen worth $222K as of Q3 2026.
  • Amgen was a new 626 Financial position in Q3 2026.
  • Amgen made up 0.09% of 626 Financial's portfolio in Q3 2026, its #119 holding.
  • 626 Financial first reported a position in Amgen in Q2 2024 and has held it in 6 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on 626 Financial's 13F filing for Q3 2026, filed 4 Nov 2026.